Financial insights of IVF

MyFinsight

For the quarter ending 2025-09-30, IVF made $5,162,499 in revenue. -$2,644,625 in net income. Net profit margin of -51.23%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31
Loss on disposal of nti	0	-1,534,517	-
Loss on discontinued operations of nti	0	-541,247	-
Income taxes	0	0	-
Total revenue	1,757,094	1,863,654	1,637,185
Research and development expenses	0	0	265,663
Impairment loss	0	1,397,353	-
(gain) loss on disposal of fixed assets	0	0	-
Cost of revenue	1,127,749	1,093,603	-
Impairment loss	-	-	14,645,069
Selling, general and administrative expenses	2,128,088	2,193,049	2,554,474
Depreciation and amortization	136,741	169,737	234,462
Cost of revenue	-	-	1,044,929
Total operating expenses	3,392,578	4,853,742	18,744,597
Loss from operations	-1,635,484	-2,990,088	-17,107,412
Gain on lease termination	0	0	-
Gain on settlement (note 17)	0	714,500	-
Gain (loss) from equity method joint ventures	12,827	-19,911	15,096
Loss on debt extinguishment	-876,165	-692,270	-
Interest expense	145,803	221,325	311,270
Total other income (expense)	-1,009,141	-219,006	-296,174
Net loss from continuing operations before income taxes	-2,644,625	-3,209,094	-17,403,586
Net loss from continuing operations	-2,644,625	-3,209,094	-
Net loss	-2,644,625	-5,284,858	-17,403,586

Basic	-0.77	-13.3	-12.53
Basic	3,447,622	397,440	1,389,141
Diluted	-0.77	-13.3	-12.53
Diluted	3,447,622	397,440	1,389,141